Parkinson's Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who experience slowness of movement, along with resting tremor (shaking when the body is still) and/or muscle stiffness.
- People whose CT scan of the appendix suggests chronic appendicitis, as assessed by two experienced specialists.
- People (and their guardians, where applicable) who are willing to give informed consent and sign the consent form for this study.
- People who have normal blood clotting function.
- People who have been taking oral Parkinson's disease medication at a stable dose for at least 2 weeks before joining the study.
Who may not be able to join:
- People who have been taking medications that block or reduce dopamine, where the dose and duration are consistent with medication-caused Parkinsonism (movement problems caused by the drug itself).
- People whose brain imaging shows normal function in the part of the brain's dopamine system involved in movement (confirm with trial site).
- People who have experienced a severe head injury or had complex brain surgery within the 5 years before joining the study.
- People who have been diagnosed with a cognitive (thinking and memory) condition outside the Parkinson's spectrum, such as Alzheimer's disease, frontotemporal dementia, or Niemann-Pick disease.
- People who have been diagnosed with a severe mental health condition — such as epilepsy, bipolar disorder, or a major depressive episode — based on DSM-V criteria.
- People who have serious conditions such as loss of consciousness, stroke, serious heart disease, diabetes, liver or kidney disease, or significant problems with vision or hearing.
- People who have severe difficulty swallowing, or who the research team determines would be unable to complete all required visits and assessments as outlined in the study plan.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Yuhua Chen, M.M.S., The First Affiliated Hospital of University of Science and Technology of China
Phone: +8615955236270
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Score of MDS Unified-Parkinson Disease Rating Scale III
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.